OMDA vs TVTX: fair value comparison
Omada Health, Inc. and Travere Therapeutics, Inc. · Updated 2026-10-19
OMDA's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. TVTX is still awaiting a full valuation verdict under our six-validated-windows standard. Within Healthcare, OMDA currently ranks higher by quality score.
| OMDA | TVTX | |
|---|---|---|
| Verdict | Awaiting full valuation | Awaiting full valuation |
| Last price | $17.63 | $49.60 |
| 12-month range | $10.94–$26.78 | $26.79–$67.52 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #71 of 301 Healthcare | #72 of 301 Healthcare |
| Quality grade | B | B |
| Leverage | — | High |
| Margin trend | Expanding | Contracting |
| Revenue growth | High | High |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | Mixed | Mixed |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: OMDA fair value analysis · TVTX fair value analysis